When is the use of long-acting adrenergic agents contraindicated?

Correct answer: During acute attacks of asthma.

Explanation

This question tests a critical safety point regarding long-acting beta-agonists (LABAs). Their delayed onset of action makes them unsuitable and dangerous for treating an acute asthma attack.

Other questions

Question 1

What is the primary goal of long-term control therapy with antiasthmatics?

Question 2

How do adrenergic bronchodilators and phosphodiesterase inhibitors both work to produce bronchodilation?

Question 3

What is the primary mechanism of action for corticosteroids when used as antiasthmatics?

Question 4

Which class of antiasthmatic agents should NOT be used during acute attacks of asthma?

Question 5

In which patient population should adrenergic bronchodilators be used with caution?

Question 6

What is the effect of cimetidine when co-administered with theophylline?

Question 7

When a patient is using both an inhalation bronchodilator and another inhalation medication, what is the recommended procedure for administration?

Question 8

How long before a meal should oral doses of glycopyrrolate be administered?

Question 9

What is the minimum recommended application time for a scopolamine transdermal patch before travel?

Question 10

What is the mechanism of action for leukotriene receptor antagonists and mast cell stabilizers?

Question 11

What is the potential outcome of concurrently using adrenergic bronchodilators with other adrenergic agents?

Question 12

According to the text, the anticholinergic drug ipratropium produces bronchodilation by decreasing intracellular levels of which substance?

Question 13

Besides inhaled corticosteroids, which other two classes of antiasthmatic medications are contraindicated for use during acute asthma attacks?

Question 14

What is a key precaution regarding the discontinuation of corticosteroid therapy?

Question 15

What potential electrolyte imbalance can be caused by corticosteroids, which may be additive with the use of potassium-losing diuretics?

Question 16

How long before a meal should oral doses of propantheline be administered?

Question 17

The risk of digoxin toxicity may be increased due to what potential effect of corticosteroids?

Question 18

What is a key nursing assessment for patients taking adrenergic bronchodilators or anticholinergics, besides respiratory status?

Question 19

What advice should be given to a patient about their antiasthmatic medication if the usual dose fails to produce the desired results?

Question 20

What is the waiting period recommended between using a bronchodilator inhaler and administering other inhalation medications?

Question 21

Chronic use of systemic corticosteroids should be avoided in children and during which other two conditions?

Question 22

How do phosphodiesterase inhibitors increase intracellular levels of cAMP?

Question 23

What is the primary desired outcome for a patient receiving antiasthmatic therapy?

Question 24

What important piece of advice should be given to patients taking antiasthmatics regarding lifestyle habits?

Question 25

What is a potential negative consequence of using corticosteroids in patients with diabetes?

Question 26

Inhaled corticosteroids are contraindicated during acute attacks of asthma. This contraindication is shared with long-acting adrenergic agents and which other class of medication?

Question 27

Which of the following is an identified potential nursing diagnosis related to the patient's understanding of their antiasthmatic medication regimen?

Question 28

Corticosteroids may decrease the effectiveness of which class of medications?

Question 29

If a patient taking an antiasthmatic experiences worsening symptoms after treatment, what is the recommended action?

Question 30

What is the shared mechanism of action of Adrenergic bronchodilators and phosphodiesterase inhibitors?

Question 31

What is the specified administration timing for oral scopolamine relative to meals?

Question 32

In which patient population should anticholinergics be used with caution?

Question 33

What type of patient advice should be provided regarding the concurrent use of adrenergic bronchodilators and other adrenergic agents?

Question 34

If a patient experiences toxic effects from their antiasthmatic medication, what should they be advised to do?

Question 35

How does ipratropium, an anticholinergic, achieve bronchodilation?

Question 36

The administration of a scopolamine transdermal patch should occur how long before travel?

Question 37

Which nursing assessment is specifically highlighted for patients taking adrenergic bronchodilators?

Question 38

How many minutes should elapse between using a bronchodilator inhaler and administering another inhalation medication?

Question 39

What is the consequence of the interaction between cimetidine and theophylline?

Question 40

According to the text, which class of antiasthmatics acts by decreasing airway inflammation?

Question 41

What is the general use of antiasthmatic agents?

Question 42

Adrenergic bronchodilators increase the production of what substance to cause bronchodilation?

Question 44

Chronic use of which class of antiasthmatics should be avoided in lactating patients?

Question 45

The administration of oral glycopyrrolate is recommended to occur how many minutes before meals?

Question 46

Which of the following is an identified potential nursing diagnosis related to the physiological state of a patient with asthma?

Question 47

A patient is advised to use their bronchodilator inhaler first. How long should they wait before administering other inhalation medications?

Question 48

What should a patient using antiasthmatics be counseled to avoid to reduce respiratory irritation?

Question 49

What potential adverse effect should be monitored in a patient with diabetes who is undergoing corticosteroid therapy?

Question 50

According to the 'Implementation' section, what is the minimum application time for a scopolamine transdermal patch before it is needed for travel?